Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cytomegalovirus glycoprotein vaccine - sanofi pasteur

Drug Profile

Cytomegalovirus glycoprotein vaccine - sanofi pasteur

Latest Information Update: 26 Jul 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chiron
  • Developer National Institute of Allergy and Infectious Diseases; sanofi pasteur; University of Alabama at Birmingham
  • Class Cytomegalovirus vaccines; Glycopeptides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Cytomegalovirus infections

Most Recent Events

  • 26 Jul 2015 No recent reports of development identified - Phase-II for Cytomegalovirus infections in USA (IM)
  • 15 Sep 2009 Efficacy data from a phase II trial in Cytomegalovirus infections presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2009)
  • 18 Mar 2009 Interim efficacy and safety data from a phase II trial in Cytomegalovirus infections released by University of Alabama at Birmingham
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top